Tue.Jul 23, 2024

article thumbnail

Discovering My Path: My Journey as a Pharmacy Student at the University of Findlay

Pharmacy Is Right For Me

Hey there, future pharmacists! I’m Shelby, a student pharmacist at the University of Findlay (UF), and I’m here to share my journey with you. If you’re thinking about a career in pharmacy or just curious about what it’s like, you’re in the right place! Falling in Love with Findlay My adventure started the summer before my senior year of high school at Findlay’s Summer Pharmacy Camp.

article thumbnail

Health Care Providers Increasingly Believe Pharmacists Should Take on More Primary Care Duties

Drug Topics

A survey conducted by Surescripts, a health care solutions company, explored the attitudes of pharmacists and prescribers towards ongoing issues and challenges currently facing the industry.

209
209
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Jeff Shuren, medical devices head at FDA, to leave the agency

STAT

Jeffrey Shuren, longtime chief regulator of medical devices at the Food and Drug Administration, announced to staff on Tuesday that he is leaving the agency, according to six sources and an email reviewed by STAT. Shuren, who spent 28 years at the agency, started his FDA career in the Commissioner’s Office in 1998. He became director of the Center for Devices and Radiological Health in 2009 and has served in that position ever since.

FDA 141
article thumbnail

Monoclonal Antibody to Prevent RSV in Infants Shows Positives Results in Phase 2b/3 Study

Drug Topics

MK-1654 (clesrovimab) met its primary efficacy endpoint of incidence of patients with RSV-associated medically attended lower respiratory infections (MALRI) through Day 150.

151
151
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Hospitals, labs, and health departments try to cope with blood culture bottle shortage

STAT

Hospitals across the country are facing a severe shortage of supplies of blood culture bottles, critical tools for diagnosing serious and sometimes life-threatening bloodstream infections. The Centers for Disease Control and Prevention sent out an alert Tuesday to health care providers, laboratory professionals, health care facility administrators, and state, tribal, local, and territorial health departments warning of the shortage of Bactec blood culture medium bottles, marketed by Becton Dicki

Hospitals 140
article thumbnail

Healthcare advocates spent millions this quarter for policy change. Here are the top 30 spenders

Fierce Healthcare

An analysis by Fierce Healthcare identified the top 30 healthcare organizations that burned through the most cash lobbying Congress for healthcare policy changes in the second quarter. | In the second quarter, 14 healthcare organizations spent more than a million dollars lobbying the federal government for healthcare policy change. The leaders of the pack were the American Hospital Association, AARP and the American Medical Association, followed by a slew of payers.

Hospitals 133

More Trending

article thumbnail

PBMs defend business practices — but lawmakers aren’t convinced

Fierce Healthcare

Lawmakers bashed the business practices of pharmacy benefit managers during a House Committee on Oversight and Accountability hearing Tuesday. | A contentious hearing between PBM CEOs and the House Commitee on Oversight and Accountability reinforced recent federal angst toward pharmacy benefit managers, but little new ground was made.

131
131
article thumbnail

STAT+: U.S. Patent Office software mistakes extend patent life for drugs and need to be fixed, researchers say

STAT

Amid concerns that the pharmaceutical industry abuses the U.S. patent system, a new paper suggests one way to crack down on the problem — amend a little-known method for correcting mistakes that lengthen the life of a patent and, consequently, can greatly add to the cost of medicines. The idea is to improve the way administrative delays are handled at the U.S.

article thumbnail

Drug Expenditures Must Be Addressed for State Spending Targets to Be Useful

Drug Topics

Industry experts explored the increase in US prescription drug spending and how state spending targets come into play regarding patients’ rising out-of-pocket costs.

112
112
article thumbnail

STAT+: A pricey Gilead HIV drug could be made for dramatically less than the company claims, researchers say

STAT

Following the release of widely touted study results for a Gilead Sciences HIV treatment, a new analysis finds the medicine — called lenacapavir — could be made for as little as $26 to $40 per person each year, which the researchers argue could alleviate concerns about limited access in many countries. The medicine drew considerable attention last month after a late-stage clinical trial found that twice-a-year injections completely protected cisgender women from contracting HIV.

134
134
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Intermittent Fasting and Meal Replacements Improved Short-Term Glycemia

Pharmacy Times

A 5:2 intermittent fasting plan combined with meal replacement had better positive outcomes compared with metformin and empagliflozin.

139
139
article thumbnail

STAT+: CVS and its PBM agree to pay $45 million to Illinois for failing to pass drug rebates

STAT

CVS Caremark, one of the largest pharmacy benefit managers in the country, agreed to pay at least $45 million to the state of Illinois to settle allegations that rebates were not passed through during a recent four-year period, according to a document obtained by STAT. At issue is a complicated, behind-the-scenes relationship between the PBM and several related entities — in particular, a so-called group purchasing organization — that allegedly obscured rebates paid by drug manufac

article thumbnail

Walgreens receives $25M BARDA grant for COVID-19 vaccine trial

Fierce Healthcare

Walgreens has received $25 million in grant funding to conduct a decentralized clinical trial assessing how well a person vaccinated against COVID-19 is protected from future infections. | The award comes from a consortium funded by the Biomedical Advanced Research and Development Authority (BARDA), embedded in the U.S. Department of Health & Human Services.

Vaccines 111
article thumbnail

STAT+: House hearing keeps pressure on PBM practices while Congress considers reforms

STAT

The House Oversight Committee kept pressure on drug middlemen at a hearing today that focused on a new committee report that criticizes industry practices. Pharmacy benefit managers steer patients to PBM-owned pharmacies while underpaying competing pharmacies, according to the report, which highlights concerns that lawmakers have been pounding for years.

Packaging 121
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

HCA Healthcare boosts 2024 revenue, earnings forecast, propelled by strong patient demand

Fierce Healthcare

HCA Healthcare's stock jumped Tuesday morning as the hospital chain reported better-than-expected performance in the second quarter and boosted its 2024 guidance. | HCA Healthcare's stock jumped Tuesday morning as the hospital chain reported better-than-expected performance in the second quarter and boosted its 2024 guidance.

Hospitals 111
article thumbnail

STAT+: Medical groups are divided over Biden plan to loosen DEA restrictions on marijuana

STAT

WASHINGTON — The Biden administration’s proposal to loosen federal restrictions on marijuana is dividing some of the nation’s top medical professionals. The nation’s largest and most powerful doctors group, the American Medical Association, has raised multiple concerns with the move, which is known as rescheduling. The American Psychiatric Association has said the drug should remain a Schedule I substance, like heroin and cocaine, one deemed to have no proven medical

121
121
article thumbnail

Stretch your organization’s potential with a flexible EHR

Fierce Healthcare

By Laura Kohlhagen, MD, MBA, Chief Medical Officer for Sunrise™, Altera Digital Health | Many EHRs lack flexibility. So, what makes an EHR truly flexible, and how can greater flexibility get healthcare organizations where they want to go?

107
107
article thumbnail

STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies

STAT

When Sanjaya Singh left Johnson & Johnson in 2021, his former colleague Peter Lebowitz paid close attention. Singh had been a mainstay in the immunology and oncology fields, helping to invent the blockbuster drug Skyrizi and several other treatments during stints at Johnson & Johnson and Boehringer Ingelheim. “If Sanjaya Singh is doing something, you want to watch it,” Lebowitz said.

117
117
article thumbnail

HIV ‘vaccine’ could be made for just $40 a year for every patient

The Guardian - Pharmaceutical Industry

Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say A new drug described as “the closest we have ever been to an HIV vaccine” could cost $40 (£31) a year for every patient, a thousand times less than its current price, new research suggests.

Vaccines 111
article thumbnail

Opinion: Fixing the reimbursement and coverage divide between ‘breakthrough’ drugs and medical devices

STAT

The Food and Drug Administration designates as “breakthrough” technologies certain drugs and devices. This designation helps expedite the development and review of therapies intended to treat serious conditions that may offer improvements over available therapies. Once breakthrough drugs and devices are approved, however, devices face a far less predictable pathway and a longer timeline to achieving reimbursement, including coverage by payers such as Medicare, compared to breakthro

FDA 106
article thumbnail

FDA Releases Draft Guidance on Essential Drug Delivery Outputs

The FDA Law Blog

By Adrienne R. Lenz, Principal Medical Device Regulation Expert — For several years, FDA has requested that sponsors of drug or biologic led combination products identify essential performance requirements (EPRs) related to the device constituent in their applications. EPRs were usually requested in the context of design controls, although 21 C.F.R. § 820.30 does not use this term.

FDA 105
article thumbnail

Pharmacists Play Key Role in Selecting Best RSV Vaccine for Older Adults

Pharmacy Times

Differentiating between the 3 available options can help identify which is best for individual patients.

Vaccines 132
article thumbnail

Agilent builds its CDMO arm with $925m Biovectra buy

pharmaphorum

Agilent has boosted its contract development and manufacturing organisation (CDMO) capacity with a $925 million deal to buy Biovectra, a Canadian provider of fill-and-finish services and active pharmaceutical ingredients (APIs).It's a statement of intent from Agilent, whose primary business is lab instrumentation and equipment, suggesting that it intends to grow the outsourcing side of its business, which is currently focused on the production of oligonucleotide and peptide medicines.

105
105
article thumbnail

How long does hydroxyzine last?

The Checkup by Singlecare

Hydroxyzine is a first-generation antihistamine that can be used to treat a number of different conditions, including anxiety, insomnia, and allergic reactions like hives. This medication comes in tablet, capsule, and syrup form and is sold under the brand names Vistaril and Atarax. If you’re prescribed hydroxyzine, you might be wondering how long each dose lasts, how long it takes to kick in, and what side effects to expect.

Dosage 104
article thumbnail

Epic, Abridge, and Mayo Clinic to leverage AI to ease nursing workflow

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Wastewater surveillance program sheds testing sites Sewage analysis has been in the spotlight recently as experts warn of an ongoing summer Covid surge.

article thumbnail

Welsh rugby great fronts UK atrial fibrillation campaign

pharmaphorum

Former Welsh rugby union captain Alum Wyn Jones is the face of a new awareness campaign launching in the UK today to draw attention to atrial fibrillation (AF), an irregular and potentially life-threatening heart rhythm abnormality.

101
101
article thumbnail

Contradictory coverage decisions in North Carolina

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. In an unfortunate twist of fate, an Oscar Mayer Weinermobile crashed into another vehicle and flipped on its side yesterday while driving around Chicago, famously known for its hot dogs. Thankfully, no injuries were reported.

100
100
article thumbnail

Analysis Determines Body Dysmorphic Disorder Is the Most Common in Adolescent Girls

Pharmacy Times

The findings also demonstrate that body dysmorphic disorder is also associated with high levels of comorbid psychopathology, risk, and psychosocial impairment.

138
138
article thumbnail

VA disputes claim that removing race from lung tests would greatly alter disability payments

STAT

Veterans Affairs department officials said Monday they have launched a study to determine how removing race from widely used lung function tests may affect disability benefits for veterans, and they expect the impact to be much smaller than predicted in a study published earlier this year. They also said veterans who may have heard about the issue should not be concerned about any sudden changes to their benefits.

95
article thumbnail

Orange Juice Can Aid Absorption of Iron

Pharmacy Times

Vitamin C can improve levels of Nonheme Ferrous Fumarate or Ferrous Sulfate in the body

131
131
article thumbnail

Amid Wegovy and Ozempic boom, Novo eyes new facility with 200-acre land buy in Denmark

Fierce Pharma

After making major manufacturing outlays in places like China and the United States earlier this year, Novo Nordisk is returning to its Danish roots. | Earlier this month, Novo Nordisk purchased a 200-acre site in Odense, Denmark’s third largest city, the company has confirmed. Novo is now set to kick off preparatory excavation work for a potential new production plant.

94
article thumbnail

GSK's Dovato matches rival Biktarvy with less weight gain

pharmaphorum

GSK has challenged Gilead's HIV behemoth Biktarvy, presenting data that its competing therapy Dovato is equally effective and associated with less weight gain.

97
article thumbnail

Q&A: The Superman Pharmacist Shares His Journey from Pharmacy School to Pharmacy Ownership

Drug Topics

In part 1 of a recent conversation on Over the Counter, Mayank Amin, PharmD, RPh, MBA, shared his journey from pharmacy school to pharmacy ownership.

86
article thumbnail

12 Questions with Irina Spirieva

pharmaphorum

Irina Spirieva, from Besins Healthcare, answers 12 intriguing questions about her journey in the healthcare industry. Learn more about her experiences and insights.

95